1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Jeremy Tavaré is Professor of Biochemistry and Director of Research (Health), a strategic research role sitting across the Faculties of Biomedical Science and Health Science.  Prior to that he was the founder Director of the Elizabeth Blackwell Institute for Health Research at the University of Bristol (and was PI of the University of Bristol first three Wellcome Trust Institutional Strategic Support Funding awards). His total lifetime research funding income currently exceeds £50M.

He is Deputy Director of SPHERE (Sensor Platforms for Health in the Residential Environment) a large interdisciplinary project which brings together engineers, clinicians, communities and patients to develop passive sensor systems to monitor people’s behavior in their own home.  Small changes in patterns of activity, gait, mood or energy consumption (gas, electricity, water) would be indicative of a problem which could be communicated to a carer or GP, for example, to keep people of all ages healthy in their own homes.  Jeremy’s role in the project is to connect the engineers with clinicians and other health care professionals.

He is also a Co-director for the £5.2M Wellcome Trust-funded GW4 Clinical Academic PhD Training Programme for talented medical, veterinary and dental graduates, and sits on the External Advisory Board for the MRC BioMed Doctoral Training Programme.

Jeremy obtained his BSc and PhD degrees in Biochemistry at Bristol, which was followed by a period as an MRC Travelling Fellow at the Howard Hughes Medical Institute in Dallas.  He then returned to Bristol as a British Diabetic Association Senior Research Fellow.  He was Director of Bristol’s MRC Cell Imaging Facility for ten years and then Chairman of the Bristol Proteomics Facility. He has been a Professor of Biochemistry since 1999 and was Faculty Research Director for the Faculty of Medical and Veterinary Sciences from 2010 to 2012. In 2001 he cofounded the drug discovery company ProXara Biotechnology Ltd and was Non-executive Director of Bioganix plc between 2007 and 2009. 

Jeremy runs a research group investigating the mechanism of insulin action on glucose uptake and the role of protein kinases in lung cancer, with a specific interest in protein kinase B (aka Akt).  His research has become increasingly translational and as a result he has forged several strong links with clinicians in Bristol and around the UK. His work is funded by grants from the Wellcome Trust, DiabetesUK, Cancer Research UK and industry.

Outside the University he has served on research boards for DiabetesUK and the Medical Research Council, and between 2004-6 was Deputy Chairman of the MRC Physiological Systems and Clinical Sciences Board.  Currently he is Chairman of the MRCs Non-clinical Training and Careers Fellowships Panel.  He is an external examiner at the University of Cambridge (1st Tripos and 2nd MB for medical and verterinary students) and previously at the University of Bath (Biology and Biochemistry 4 year MSc).

Outside of academia, he was a semi-professional cricketer for Gloucestershire CCC and played at Lords with the Optimists CC (now Bristol CC) in the 1992 National Club Championship beating Kendal CC.

Fingerprint Dive into the research topics where Jeremy M Tavare is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Bristol Confidence in Concept 2019

Tavare , J. M.


Project: Research

Bristol Confidence in Concept 2019

Tavare , J. M.


Project: Research, Parent

Research Output

Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer

O'Flaherty, L., Shnyder, S. D., Cooper, P. A., Cross, S. J., Wakefield, J., Pardo, O. E., Seckl, M. J. & Tavare, J., 10 Apr 2019, In : PLoS ONE. 14, 4, p. e0214610 7 p., e0214610.

Research output: Contribution to journalArticle (Academic Journal)

Open Access
  • 177 Downloads (Pure)

    Isoform-specific AMPK association with TBC1D1 is reduced by a mutation associated with severe obesity

    Thomas, E., Hook, S. C., Grey, A., Chadt, A., Carling, D., Al-Hasani, H., Heesom, K. J., Hardie, G. & Tavare, J., Sep 2018, In : Biochemical Journal. 475, 18, p. 2969-2983 15 p., 475.

    Research output: Contribution to journalArticle (Academic Journal)

    Open Access
  • 5 Citations (Scopus)
    246 Downloads (Pure)

    Insulin promotes Rip11 accumulation at the plasma membrane by inhibiting a dynamin- and PI3-kinase-dependent, but Akt-independent, internalisation event

    Boal, F., Hodgson, L. R., Reed, S. E., Yarwood, S. E., Just, V. J., Stephens, D. J., McCaffrey, M. W. & Tavaré, J. M., Jan 2016, In : Cellular Signalling. 28, 1, p. 74-82 9 p.

    Research output: Contribution to journalArticle (Academic Journal)

    Open Access
  • 224 Downloads (Pure)


    • 1 - Research and Teaching at External Organisation

    Collaboration on insulin action

    Jeremy M Tavare (Contributor)


    Activity: Other activity types - Research and Teaching at External Organisation